Journal Home
Search for

Volume 6, Issue 9, Pages 3448-3456 (September 2010)


View previous. 11 of 51 View next.

Shaping the micromechanical behavior of multi-phase composites for bone tissue engineering

Shivakumar I. Ranganathana, Diana M. Yoonb, Allan M. Hensleed, Manitha B. Nairb, Christine Smida, F. Kurtis Kasperb, Ennio Tasciottia, Antonios G. Mikosb, Paolo DecuzziacCorresponding Author Informationemail address, Mauro Ferrariabd

Received 1 December 2009; received in revised form 26 February 2010; accepted 19 March 2010. published online 25 March 2010.

Abstract 

Mechanical stiffness is a fundamental parameter in the rational design of composites for bone tissue engineering in that it affects both the mechanical stability and the osteo-regeneration process at the fracture site. A mathematical model is presented for predicting the effective Young’s modulus (E) and shear modulus (G) of a multi-phase biocomposite as a function of the geometry, material properties and volume concentration of each individual phase. It is demonstrated that the shape of the reinforcing particles may dramatically affect the mechanical stiffness: E and G can be maximized by employing particles with large geometrical anisotropy, such as thin platelet-like or long fibrillar-like particles. For a porous poly(propylene fumarate) (60% porosity) scaffold reinforced with silicon particles (10% volume concentration) the Young’s (shear) modulus could be increased by more than 10 times by just using thin platelet-like as opposed to classical spherical particles, achieving an effective modulus E ∼ 8GPa (G ∼ 3.5GPa). The mathematical model proposed provides results in good agreement with several experimental test cases and could help in identifying the proper formulation of bone scaffolds, reducing the development time and guiding the experimental testing.

a Department of Nanomedicine and Biomedical Engineering, The University of Texas Health Science Center, Houston, TX, USA

b Department of Bioengineering, Rice University, Houston, TX, USA

c BioNEM, University of Magna Graecia, Catanzaro, Italy

d Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Corresponding Author InformationCorresponding author at: Department of Nanomedicine and Biomedical Engineering, The University of Texas Health Science Center, Houston, TX, USA. Tel.: +1 713 500 3363.

PII: S1742-7061(10)00155-8

doi:10.1016/j.actbio.2010.03.029


View previous. 11 of 51 View next.